Only in America. For recovered employees, more than 50,000 senior dismissals are required. Their business and review of employees is important for the development of the pharmaceutical industry. They will bring further changes in the future. I think the biggest opportunity is to be a developing country, where the need for treatment is very limited, very limited medicine, or there is no treatment like the United States at all. As you can see from the movie, the market growing by 2020 will expand by 20%.
INTRODUCTION: In this article I will describe every aspect of importing medicines to the United States into Canada. Medicine and medical expenses are high in the United States, so I wrote a lot about this issue last year. There are several parliamentary bills that can promote Canadian drug imports to the United States. The driving force behind this problem is the price difference between claim reliability and author claims. This article deepens the understanding of the subject and follows a critical style for improving the critical evaluation of research papers and information published in published journals (Behren & Losen, 2005). A research paper by Pflugrath, Martinov-Bennie & Chen (2007) aims to analyze the impact of organizational ethics on the judgment of accountants and auditors.
The cost of prescription drugs has risen sharply over the past few years and is a major problem in the United States. In the article published in the business outlook "high drug prices, elderly people in the United States and pharmaceutical expenditure management policy" pointed out that in the countries of the Organization for Economic Cooperation and Development (OECD), the US has spent about 15% of medical care at home It was done. Gross Domestic Product (GDP) (Okunade). Increasing the cost of prescription drugs is one of the main factors leading to an increase in the overall cost of medical expenses. "According to the National Health Care Management Laboratory in Washington, DC, Americans spent an average of $ 154.5 billion on prescription drugs since 2001. They spent $ 78.9 billion in 1997 (Isax). There are many reasons for the cost of medicine to rise, but there are increasing demand for medicine, abuse and problems of "moral hazard", patent protection for brand drugs.
Expensive branded medicine accounts for only 11% of all prescription medicines 1 1 is the source of most pharmaceutical income ($ 37 billion in 2015). Normally, after 10 to 15 years, brand drugs lose patent protection and release low-cost generic drug 3 (2015, the US spent a relatively modest 88 billion dollars against generic drugs, these Of medicines accounted for 89% of all prescription medications). Unlike most other aspects of healthcare, medicines become more versatile and total expenditure of retail medicines is only about 12% of total healthcare expenditure. This is almost the same as in 1972. Drug expenditure is still the same proportion of overall health expenditure, but we now have more and better treatment